UAE rolls out Sinopharm COVID-19 vaccine to children aged 3-17

DUBAI: The United Arab Emirates will start providing China’s Sinopharm COVID-19 vaccine to children aged 3-17, the government said. It cited the health ministry as saying the decision comes after clinical trials and extensive evaluations, without providing any details. Authorities

Chinese drugmakers to supply more than half a billion vaccines to COVAX

GENEVA: The Global Alliance for Vaccines and Immunization (GAVI) has signed two advance purchase agreements with Chinese drugmakers Sinopharm and Sinovac to provide up to 550 million COVID-19 vaccines to the COVAX programme. The new deals include up to 170

Sinopharm’s COVID-19 vaccine 72.8% effective in latest study

BEIJING: Two COVID-19 vaccines from China’s Sinopharm showed more than 70% efficacy against symptomatic cases, according to the first detailed result of a large late-stage study published to the public. A vaccine developed by a Wuhan-based subsidiary of Sinopharm was

UAE to manufacture COVID-19 vaccine from China’s Sinopharm

DUBAI: A new pharmaceutical plant in Abu Dhabi will start making a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year. The vaccine will be made under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42

Pakistan to purchase 1.2m vaccine doses from China’s Sinopharm

ISLAMABAD: Pakistan had decided to purchase 1.2 million doses of coronavirus vaccine from China’s Sinopharm which has recently been approved by the Chinese regulator. Minister for Science and Technology Fawad Chaudry said the Cabinet Committee has decided to initially purchase

China gives first COVID-19 vaccine approval to Sinopharm

BEIJING: China approved its first COVID-19 vaccine for general public use, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter. Although no detailed efficacy data of the vaccine

China’s Sinopharm vaccine ‘79% effective’ against COVID-19

BEIJING: The phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said, lower than those developed by Pfizer-BioNTech and Moderna. China has been racing against the West to develop its own

China’s Sinopharm vaccine has 86% efficacy against COVID-19, says UAE

DUBAI: An experimental coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) has 86% efficacy, the health ministry of the United Arab Emirates said, citing an interim analysis of late-stage clinical trials. While the positive data comes soon after last